In this article, Jigar Shah, Senior Group Leader in Analytical Development at Baroque Pharmaceuticals, explores the intricacies of capsule dissolution testing.
What is dissolution?
Dissolution tests determine the rate and extent of release of the drug substance from a drug product under specific conditions and specific times. Dissolution tests help to evaluate bioavailability of drug substances and are part of release criteria during quality control testing. Dissolution tests are also undertaken during product development to study batch-to-batch consistency, evaluate stability of the product and to assure compliance with regulations. The regulatory agencies use the dissolution test to provide a quality connection from a pivotal bio batch to the commercialised product.1
For this reason, the dissolution test development and validation are critical factors in ensuring that the test is robust and clinically relevant.
Dissolution of capsule formulation
As is the case with other oral solid dosage forms, USP Apparatus 1 (basket), USP Apparatus 2 (paddles), USP Apparatus 3 (reciprocating cylinder), and USP Apparatus 4 (flow-through cell) are most often chosen as the dissolution apparatus for capsules.
Are you looking to explore how lipid formulations in softgels can enhance drug absorption and bioavailability. Register for our upcoming webinar to find out!
3 September 2025 | 3:00 PM BST | FREE Webinar
This webinar will delve into the different types of lipid formulations, such as solutions, suspensions, emulsions, and self-(micro)emulsifying systems. Applications span diverse therapeutic areas including HIV therapy, oncology, immunosuppressants, and emerging treatments like medicinal cannabis (eg, CBD).
What You’ll Learn:
Lipid formulation development and screening tools for optimisation
Key steps in scale-up and industrialisation to ensure consistency and efficiency
Impact of lipid-based softgels on drug delivery and patient outcomes.
Generally, basket or paddle with/without sinkers are preferred for capsules.
However, several specific benefits and drawbacks must be considered in selecting and using the dissolution apparatus for capsules:
Capsules may be filled with a material that has a specific gravity less than that of water, meaning the capsules may float in an aqueous dissolution medium
Instead of dissolving completely during the dissolution test, the capsule shell may soften and disintegrate into a sticky or waxy mass that can adhere to any point in the dissolution vessel and in different areas in different vessels, generating high variability in the results
The capsule fill material may form a film on the surface of the dissolution medium during the course of the test.
Capsules can be classified as two main types based on the physical characteristics of the shell: soft capsules (softgels) and hard capsules (hardgels).
Both softgels and hardgels are composed of a polymer, eg, gelatine, starch, or a cellulose derivative such as hypromellose (HPMC) or other polymers, a plasticiser and water.2
Gelatine properties
Hard gelatine capsule example
Gelatine capsules are a widely used dosage form, both for pharmaceutical drug products as well as dietary supplements.
Gelatine is obtained from the partial hydrolysis of collagen. The most abundant animal protein in nature, collagen is an insoluble, highly ordered fibrous protein that is the primary fibrous component of bone, skin and connective tissue.
Gelatine capsule shells are prepared from a molten gel mass that is composed of gelatine and a plasticiser dissolved in an aqueous vehicle.
For hard gelatine capsule (hardgel) shells, water acts as both the plasticiser and the vehicle.
For soft gelatine capsule (softgel) shells, small polyhydroxy compounds such as glycerol, sorbitol and maltitol are typically used as plasticisers.
Soft gelatine capsule example
Several issues affect the development of a dissolution procedure and the dissolution behaviour for capsules, including:
Properties of capsule shell material
Properties of the fill material
Interaction between capsule shell material and fill material.
The capsule dissolution process involves three stages:
Rupture of the capsule shell
Release and dispersion of the capsule fill material
Dissolution of the active ingredient in the medium.
Rupture of the capsule shell is necessary for release of filled materials and dissolution of active ingredient, however, due to cross-linking of capsule shell (containing gelatine) this will not occur.2
What is cross-linking?
Cross-linking involves covalent bonding of the amine group of a lysine side chain of one gelatine molecule to a similar amine group on another molecule. The covalent bonding is irreversible”
Gelatine in the presence of certain compounds, mainly aldehydes, or in high humidity and high temperature conditions can cross-link.
Cross-linking involves covalent bonding of the amine group of a lysine side chain of one gelatine molecule to a similar amine group on another molecule. The covalent bonding is irreversible.
Cross-linking can be caused by agents present in the capsule fill that react with gelatine molecules, resulting in the formation of a pellicle (a thin, water insoluble skin) on the internal surface of the shell. Less often, a pellicle may form on the external surface of the shell, arising from reactive agents present in, or derived from, the intermediate or final packaging components.
Such pellicle formation on the internal or external surface of the gelatine capsule shell prevents the capsule fill from being released during dissolution.
A weaker type of cross-linking involves complexation of free carboxylic acid groups from two different gelatine molecules with trivalent metal ions such as Fe3+ and Al3+. These cations can be found in some of the dyes used as colourants or as low-level contaminants of excipients.2
Common causes of cross-linking include:
Aldehydes present in active pharmaceutical ingredients, excipients, packaging materials, or degradants formed in situ during storage
High humidity and high temperature
Substances that facilitate a cross-linking reaction – reducing sugar
Substances that promote decomposition of stabiliser in corn starch (hexamethylenetetramine) resulting in the formation of ammonia and formaldehyde
Rayon coilers that contain an aldehyde functional group (furfural)
Polyethylene glycols that may auto-oxidise to form aldehydes
UV light, especially in the presence of high heat and humidity.2
Dissolution of cross-linked capsules
In vitro dissolution testing of cross-linked capsules can result in slower release of the drug, variability in release or no release at all.
The US Pharmacopeia therefore allows the use of enzymes in the dissolution medium and requires tier two dissolution testing if the gelatine capsule fails dissolution test due to evidence of cross-linking.
The degree of cross-linking is not uniform within one capsule or among different capsules. Consequently, dissolution results will have higher variability when gelatine capsules are cross-linked.
The dissolution failure by cross-linking should be properly documented and justified.
Cross-linking in the gelatine can be evidenced by (a) visual observation of the presence of a thin membrane around the capsule or the capsule being transformed into a gelatinous mass with no rupture (b) Spectroscopic techniques such as carbon 13-nuclear magnetic resonance, Fourier transform near-infrared, Fourier transform infrared.2
Enzymes will digest the pellicle, remove the cross-linking and release the drug from inside the shell.
Tier two concept
Use of enzymes based on pH of QC release dissolution media is the better solution for cross-linking.
Enzymes are used for removing cross-linking in two ways: one way is with simple physiological buffer media and another is using a medium with surfactant.
Use of enzymes: Tier two concept – option 1
Tier two dissolution testing is included in the USP Chapter <711> with details of the cross-linking issue.1
USP general chapter <1094> Capsule-Dissolution Testing and Related Quality Attributes has described capsule cross-linking in depth.2
Use of enzymes depends on the pH of the dissolution media, for example:
Dissolution medium with pH ≤4.0
A quantity of pepsin that results in an activity of not more than 750,000 units/L of dissolution medium is used.
Dissolution medium with pH >4.0 and <6.8
A quantity of papain that results in an activity of not more than 550,000 units/L of dissolution medium or a quantity of bromelain that results in an activity of not more than 30 gelatine-digesting units (GDU)/L of dissolution medium are used.
Dissolution medium with pH ≥6.8
A quantity of pancreatin that results in a protease activity of not more than 2,000 units/L of dissolution medium is used.
Tests to be carried out to ensure that selected enzymes do not adversely interact with formulation.
There are several challenges associated with this option, including:
Selection of enzyme, optimisation of enzyme concentration, the need for a filter interference study, and issues related to precision, recovery, linearity and solution stability
Verification that Tier 2 dissolution does not affect the dissolution profile when compared with Tier 1 test
Qualifying / setting chromatography.3
Use of enzymes: Tier two concept – Option 2
If the dissolution medium contains surfactant or other ingredients that are known to denature the used enzyme activity, a pre-treatment step in the dissolution testing of the dosage form may be applied.
This pre-treatment consists of adding the enzyme to the specified medium without the surfactant and running the agitation for a contact/incubation time, in most cases not more than 15 minutes.
After this period, a solution containing the surfactant is added to the dissolution vessel in such a way that the final concentration of the surfactant in the vessel will be the same as the QC release media.1
The pre-treatment time is included in the total run time of the dissolution method.
Challenges associated with this option are the same as for Option 1. However, there are additional factors to consider including the optimum composition and volume required for pre-treatment, as well as optimisation of contact time.3
Conclusion
Cross-linking is the major issue in dissolution testing for gelatine capsules. Sometimes a batch fails its stability study due to cross-linking. In this instance, enzymes are the best option for achieving Q point release as per specification. This Tier 2 activity is used for gelatine capsule shells used for hard and soft gelatine capsules, as well as gelatine-coated tablet dissolution queries.
In Tier 2 option, enzymes are used as per the pH of respective QC media with proper optimisation. In Option 1, it is easy to explain media composition and procedure while for Option 2, it is difficult to explain. Pre- treatment step and incubation time should be optimised with caution and finalised. Using Tier 2 Option 1 and 2, we can save dissolution and ultimately, by regulatory justification with efficient data, file the product.4
Jigar spoke at EPR’s 2023 ‘The Future of Bio/Pharmaceutical Analysis’ online summit. Our 2024 is open for registration. Book tickets here!
About the author
Jigar Shah is a Senior Group Leader in Analytical Development Dept. of Baroque Pharmaceuticals Pvt Ltd, Gujarat, India. He has over 15 years’ of experience in the drug product life cycle analytical & quality in the pharmaceutical industry. Jigar holds a master’s degree in pharmaceutical science and is skilled in charting out strategies for drug product method development / validation and delivering quality products.
References
USP General Chapter <711> Dissolution
USP General Chapter <1092> The Dissolution Procedure: Development and Validation
USP General Chapter <1094> Capsule-Dissolution Testing and Related Quality Attributes
The Future of Bio Pharmaceutical Analysis 2023 [Internet]. Pharmaceutical Events. [cited 2024 Apr 23]. Available from: https://pharmaceutical.events/the-future-of-bio-pharmaceutical-analysis-2023/
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.